/GNRSW

GNRSW Stock - Greenrose Acquisition Corp.

Q: What is the analyst price target for GNRSW?

Analyst price target information is not currently available for GNRSW.

Q: What is GNRSW's market cap?

Market capitalization information is not currently available for GNRSW.

Healthcare|Drug Manufacturers - Specialty & Generic|OTC

$0.00-99.67%

$0.00 (-99.67%) • Mar 1

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for GNRSW

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2019

FY2020

FY2021

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta3309.14

52W High$0.00

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2021	FY2020	FY2019
Revenue	$25.39M	$28.38M	N/A
Gross Profit	$15.00M	$26.78M	N/A
Gross Margin	59.1%	94.4%	N/A
Operating Income	$9.84M	$15.61M	$-6.597
Net Income	$17.93M	$714,625	$-6.597
Net Margin	70.6%	2.5%	N/A
EPS	$1.12	$3.46	$-0.00

Company Overview

Greenrose Holding Company Inc., through its subsidiaries, engages in the production and sale of cannabis products. It engages in cultivating, processing, and packaging medical cannabis and derivative products. The company was founded in 2014 and is headquartered in Amityville, New York.

Frequently Asked Questions about GNRSW

What is GNRSW's current stock price?

Greenrose Acquisition Corp. (GNRSW) is currently trading at $0.00 per share. The stock has moved -99.67% today.

What is the analyst price target for GNRSW?

No analyst price targets are currently available for this stock.

What sector is Greenrose Acquisition Corp. in?

Greenrose Acquisition Corp. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the OTC exchange.

What is GNRSW's market cap?

Greenrose Acquisition Corp. has a market capitalization of $0.00 billion, making it a small-cap company.

Does GNRSW pay dividends?

No, Greenrose Acquisition Corp. does not currently pay a dividend to shareholders.